128 related articles for article (PubMed ID: 24719947)
1. Expanded criteria for hepatocellular carcinoma after liver transplantation: a 20-year evolution.
Lai Q; Nudo F; Mennini G; Spoletini G; Morabito V; Levi SG; Melandro F; Guglielmo N; Berloco PB; Rossi M
Hepatogastroenterology; 2013; 60(128):2039-41. PubMed ID: 24719947
[TBL] [Abstract][Full Text] [Related]
2. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.
Lei JY; Wang WT; Yan LN
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766
[TBL] [Abstract][Full Text] [Related]
3. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
Decaens T; Roudot-Thoraval F; Badran H; Wolf P; Durand F; Adam R; Boillot O; Vanlemmens C; Gugenheim J; Dharancy S; Bernard PH; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Hilleret MN; Chazouillères O; Cherqui D; Mallat A; Duvoux C
Liver Int; 2011 Jul; 31(6):792-801. PubMed ID: 21645209
[TBL] [Abstract][Full Text] [Related]
5. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
7. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
8. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
[TBL] [Abstract][Full Text] [Related]
9. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
13. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation.
Shirabe K; Taketomi A; Morita K; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Toshima T; Maehara Y
Clin Transplant; 2011; 25(5):E491-8. PubMed ID: 21518000
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
[TBL] [Abstract][Full Text] [Related]
17. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
[TBL] [Abstract][Full Text] [Related]
18. How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.
Xiao GQ; Yan L; Yang J
Hepatogastroenterology; 2014 Oct; 61(135):2077-83. PubMed ID: 25713913
[TBL] [Abstract][Full Text] [Related]
19. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
Choi HJ; Kim DG; Na GH; Hong TH; You YK
Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]